| Literature DB >> 23193423 |
Yan Zhang1, Chwan-Li Shen, Kim Peck, Jean-Michel Brismée, Susan Doctolero, Di-Fan Lo, Yik Lim, Lixing Lao.
Abstract
Background. Osteoarthritis (OA) is more prevalent in women, particularly after menopausal age. Women are more likely to seek complementary and alternative medicine (CAM) approaches. We examined the feasibility of training self-administered acupressure exercise and assessed its impact on OA symptoms among women with knee OA. Methods. Thirty-six eligible postmenopausal women were randomly assigned in the acupressure exercise group (n = 15) or the control group (n = 21) for 12 weeks. Feasibility outcomes (e.g., compliance and adverse effects) and clinical outcomes (e.g., pain, stiffness, and physical function) were assessed. Data were collected at baseline, 6 weeks and 12 weeks. Both per-protocol and intention-to-treat analysis were employed. Results. The training materials were well received. The feedback from participants suggests that self-administered acupressure exercise is easy to learn and safe to perform at home, although no statistically significant results of the clinical outcome were observed. Our findings didn't reveal superiority or inferiority of acupressure compared with usual care. Conclusion. Acupressure exercise is feasible to be trained among postmenopausal women with knee osteoarthritis. Due to the limitations of this study such as small sample size and high attrition rate, acupressure's efficacy needs to be further explored in larger scale studies with more rigorous design.Entities:
Year: 2012 PMID: 23193423 PMCID: PMC3489108 DOI: 10.1155/2012/570431
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Acupoints used in the protocol.
Participants' baseline characteristics.
| Participant's characteristics | Acupressure group ( | Control group ( |
|
|---|---|---|---|
| Age | 63.47 ± 2.64 | 59.86 ± 4.91 | 0.05a |
| Body mass index (BMI) | 28.89 ± 4.16 | 28.46 ± 4.05 | 0.76 a |
| Pain VAS | |||
| Left knee | 4.60 ± 2.64 | 4.57 ± 2.79 | 0.98a |
| Right knee | 5.00 ± 2.29 | 5.57 ± 2.29 | 0.46a |
| Self-rated general health | |||
| Good | 66.7% | 71.4% | 0.94b |
| Satisfactory | 26.7% | 23.8% | |
| Not good | 6.7% | 4.8% |
aIndependent t-test.
bChi-Square test.
Figure 2The flow of participant recruitment and retention.
Per-protocol design WOMAC subscale scores and score changes.
| WOMAC subscales | Acupressure group ( | Control group ( | Repeated measure | Mann-Whitney | ||
|---|---|---|---|---|---|---|
| Score | Score change | Score | Score change | ANOVA, |
| |
| Pain | N/A | |||||
| Baseline (0–6 week) | 13.75 ± 3.33 | − 1.30 ± 2.31 | 14.44 ± 2.99 | − 1.33 ± 2.20 | 0.91 | |
| 6 week (6–12 week) | 12.63 ± 3.70 | 0.50 ± 3.42 | 13.06 ± 3.34 | 0.44 ± 2.00 | 0.49 | |
| 12 week (0–12 week) | 13.13 ± 4.49 | −0.63 ± 3.93 | 13.50 ± 3.20 | −1.11 ± 2.79 | 0.78 | |
| Stiffness | N/A | |||||
| Baseline (0–6 week) | 6.75 ± 1.67 | −1.60 ± 2.50 | 6.56 ± 1.03 | −0.61 ± 1.69 | 0.41 | |
| 6 week (6–12 week) | 5.13 ± 2.30 | 0.50 ± 1.60 | 5.94 ± 1.77 | 0.31 ± 1.30 | 0.45 | |
| 12 week (0–12 week) | 5.63 ± 2.45 | −1.13 ± 2.90 | 6.25 ± 1.65 | −0.05 ± 1.39 | 0.28 | |
| Physical function | 0.02* | |||||
| Baseline (0–6 week) | 56.71 ± 16.60 | −9.78 ± 11.04 | 48.93 ± 10.39 | −4.18 ± 4.50 | 0.07 | |
| 6 week (6–12 week) | 43.86 ± 13.06 | 1.00 ± 9.97 | 44.40 ± 11.21 | 1.00 ± 6.55 | 0.98 | |
| 12 week (0–12 week) | 42.43 ± 15.97 | −14.29 ± 8.48 | 44.93 ± 12.48 | −4.61 ± 6.52 | 0.03* | |
| Total scores | N/A | |||||
| Baseline (0–6 week) | 77.29 ± 21.48 | −13.22 ± 14.17 | 70.40 ± 13.19 | −6.18 ± 7.08 | 0.24 | |
| 6 week (6–12 week) | 61.00 ± 18.46 | 2.00 ± 14.60 | 63.80 ± 15.25 | 1.75 ± 8.81 | 0.88 | |
| 12 week (0–12 week) | 59.71 ± 21.42 | −17.57 ± 13.40 | 64.93 ± 16.69 | −5.94 ± 8.85 | 0.07 | |
aRepeated measure ANOVA performed only when ANOVA assumptions were met. N/A indicates that ANOVA assumptions were not met.
bMann-Whitney U test performed for all subscale score changes.
*P < 0.05.
Intention-to-treat design WOMAC subscale scores and score changes.
| WOMAC subscales | Acupressure group ( | Control group ( | Repeated measure | Mann-Whitney | ||
|---|---|---|---|---|---|---|
| Score | Score change | Score | Score change | ANOVA, |
| |
| Pain | 0.83 | |||||
| Baseline (0–6 week) | 13.53 ± 2.61 | − 0.87 ± 1.96 | 14.95 ± 3.71 | − 1.14 ± 2.08 | 0.55 | |
| 6 week (6–12 week) | 12.66 ± 2.87 | 0.27 ± 2.43 | 13.81 ± 4.18 | 0.05 ± 2.25 | 0.49 | |
| 12 week (0–12 week) | 13.93 ± 3.39 | −0.60 ± 2.87 | 13.85 ± 4.05 | −1.10 ± 2.64 | 0.51 | |
| Stiffness | 0.33 | |||||
| Baseline (0–6 week) | 6.53 ± 1.64 | −1.07 ± 2.15 | 6.77 ± 1.26 | −0.37 ± 1.47 | 0.47 | |
| 6 week (6–12 week) | 5.47 ± 1.96 | 0.27 ± 1.16 | 6.38 ± 2.02 | 0.28 ± 1.15 | 0.66 | |
| 12 week (0–12 week) | 5.73 ± 2.01 | −0.80 ± 2.14 | 6.67 ± 2.08 | −0.10 ± 1.41 | 0.29 | |
| Physical function | 0.52 | |||||
| Baseline (0–6 week) | 48.33 ± 15.25 | −6.37 ± 9.57 | 48.85 ± 13.49 | −3.54 ± 4.31 | 0.51 | |
| 6 week (6–12 week) | 42.07 ± 13.33 | 0.94 ± 7.45 | 45.47 ± 14.50 | −0.46 ± 6.38 | 0.51 | |
| 12 week (0–12 week) | 43.07 ± 13.13 | −5.43 ± 10.17 | 44.95 ± 13.13 | −4.00 ± 6.08 | 0.98 | |
| Total scores | 0.95 | |||||
| Baseline (0–6 week) | 68.10 ± 18.34 | −8.31 ± 12.47 | 70.57 ± 17.92 | −5.06 ± 6.64 | 0.80 | |
| 6 week (6–12 week) | 60.20 ± 14.93 | 1.47 ± 10.88 | 65.71 ± 20.15 | −0.13 ± 8.35 | 0.53 | |
| 12 week (0–12 week) | 61.73 ± 17.58 | −6.83 ± 14.03 | 65.47 ± 18.52 | −5.19 ± 8.34 | 0.76 | |
aRepeated measure ANOVA controlled for age, baseline BMI, and baseline knee pain rating.
bMann-whitney U test performed for all subscale score changes.